| Nom anglais | Code de recherche | Phase de R&D | Entreprise | Indication | Essai clinique |
|---|---|---|---|---|---|
| SRN-001 | SRN-001 | Phase 1 Clinical | siRNAgen Therapeutics Inc | Metabolic Dysfunction-Associated Steatotic Liver Disease; Idiopathic Pulmonary Fibrosis; Chronic Kidney Disease-Mineral and Bone Disorder | Details |